SIC 3826 – Laboratory Analytical Instruments
Valuation | |
---|---|
Market Cap ($M) | 8.30 |
Enterprise Value ($M) | 7.13 |
Book Value ($M) | 14.43 |
Book Value / Share | 10.09 |
Price / Book | 0.57 |
NCAV ($M) | 0.01 |
NCAV / Share | 0.01 |
Price / NCAV | 829.57 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.38 |
Return on Assets (ROA) | -0.30 |
Return on Equity (ROE) | -0.41 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.05 |
Current Ratio | 1.17 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 3.68 |
Assets | 18.10 |
Liabilities | 3.67 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 15.20 |
Operating Income | -7.62 |
Net Income | -5.85 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -3.56 |
Cash from Investing | -0.13 |
Cash from Financing | 1.74 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
394 | 878 | 44.87 | |
1,276 | 1,352 | 94.38 | |
53 | 175 | 30.29 | |
2,717 | 843 | 322.30 | |
312 | 142 | 219.72 | |
(click for more detail) |
Similar Companies | |
---|---|
OMIC – Singular Genomics Systems, Inc. | OPTX – Syntec Optics Holdings, Inc. |
OPXS – Optex Systems Holdings, Inc | THMO – ThermoGenesis Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io